Patents by Inventor Abdullah AKBAR

Abdullah AKBAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TG2 inhibitor piperazine compounds and uses thereof
    Patent number: 10894777
    Abstract: There are provided Tissue Transglutaminase (TG2) inhibitor compounds, and compositions and methods of use thereof for the prevention or treatment of a cancer.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: January 19, 2021
    Assignees: UNIVERSITY OF OTTAWA, UNIVERSITY OF MARYLAND, BALTIMORE, UNIVERSITY OF ROCHESTER
    Inventors: Jeffrey W. Keillor, Abdullah Akbar, Richard L. Eckert, Matthew Fisher, Gail V. W. Johnson
  • TG2 INHIBITOR COMPOUNDS AND USES THEREOF
    Publication number: 20190389814
    Abstract: There are provided Tissue Transglutaminase (TG2) inhibitor compounds, and compositions and methods of use thereof for the prevention or treatment of a cancer.
    Type: Application
    Filed: April 13, 2017
    Publication date: December 26, 2019
    Applicants: UNIVERSITY OF OTTAWA, UNIVERSITY OF MARYLAND, BALTIMORE, UNIVERSITY OF ROCHESTER
    Inventors: Jeffrey W. KEILLOR, Abdullah AKBAR, Richard L. ECKERT, Matthew FISHER, Gail V. W. JOHNSON